Karl Landheer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karl Landheer has a total of 259 co-authors. Here are the top co-authors by number of shared publications:
Christoph Juchem
11 shared publications- Christoph Juchem
Department of Biomedical Engineering Columbia University Fu Foundation School of Engineering and Applied Science New York New York USA
7 shared publications - Jonathan Marchini
Regeneron Genetics Center, Tarrytown, USA
5 shared publications - Kay Chioma Igwe
Department of Biomedical Engineering Columbia University New York New York USA
5 shared publications - Kelley M. Swanberg
Institutionen för Experimentell Medicinsk Vetenskap, Medicinska Fakulteten Lunds Universitet Lund Sweden
5 shared publications - Martin Gajdošík
High-field MR Center, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
5 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (12)
Synthetic Data in MR Spectroscopy: Current Practices, Applications, and Considerations
Synthetic data generation has become an increasingly important component of methodological development in magnetic resonance spectroscopy (MRS), particularly in contexts where ground‐truth in vivo measurements are limited, noisy, or inaccessible. This review provides a structured overview of current practices in synthetic MRS data generation, with emphasis on the physical, biochemical, and computational assumptions that underpin commonly used models. A decomposition of synthetic MRS data is presented in terms of core building blocks, including basis sets, signal formation models, and metabolite parameter distributions such as concentration and relaxation properties. This framework is extended to advanced components required for realistic data synthesis, including baseline and nuisance signals, spatial encoding effects such as coil sensitivities and field inhomogeneities, k‐space sampling and gradient imperfections, as well as sample‐specific and temporal dynamics. Beyond single‐voxel modeling, synthetic data generation across multiple MRS modalities is discussed, including functional MRS, diffusion‐weighted MRS, and spectroscopic imaging, with emphasis on modality‐specific challenges such as physiological variability, motion, and confounding signal contributions. The role of synthetic data in clinical and preclinical research, acquisition optimization, software validation, and emerging artificial intelligence applications is further examined, with particular attention to domain shift and representational realism. Current practices in validation, reporting standards, and data accessibility are also reviewed, and key gaps limiting reproducibility and interoperability across studies are identified. Overall, this work provides a unified conceptual framework for synthetic MRS data generation, clarifies underlying assumptions across modeling choices, and outlines open challenges toward improving realism, standardization, and utility in both methodological and translational applications. Conducted by the MRS Synthetic Data Working Group under the Code & Data Sharing Committee of the MRS Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM), this review encompasses the existing literature, supplemented by the collective experience and in‐house methodologies of its contributors, providing a community perspective that extends beyond the published record.
- 17 November 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (12)
Open AccessSynthetic Data in MR Spectroscopy: Current Practices, Applications, and Considerations
Synthetic data generation has become an increasingly important component of methodological development in magnetic resonance spectroscopy (MRS), particularly in contexts where ground‐truth in vivo measurements are limited, noisy, or inaccessible. This review provides a structured overview of current practices in synthetic MRS data generation, with emphasis on the physical, biochemical, and computational assumptions that underpin commonly used models. A decomposition of synthetic MRS data is presented in terms of core building blocks, including basis sets, signal formation models, and metabolite parameter distributions such as concentration and relaxation properties. This framework is extended to advanced components required for realistic data synthesis, including baseline and nuisance signals, spatial encoding effects such as coil sensitivities and field inhomogeneities, k‐space sampling and gradient imperfections, as well as sample‐specific and temporal dynamics. Beyond single‐voxel modeling, synthetic data generation across multiple MRS modalities is discussed, including functional MRS, diffusion‐weighted MRS, and spectroscopic imaging, with emphasis on modality‐specific challenges such as physiological variability, motion, and confounding signal contributions. The role of synthetic data in clinical and preclinical research, acquisition optimization, software validation, and emerging artificial intelligence applications is further examined, with particular attention to domain shift and representational realism. Current practices in validation, reporting standards, and data accessibility are also reviewed, and key gaps limiting reproducibility and interoperability across studies are identified. Overall, this work provides a unified conceptual framework for synthetic MRS data generation, clarifies underlying assumptions across modeling choices, and outlines open challenges toward improving realism, standardization, and utility in both methodological and translational applications. Conducted by the MRS Synthetic Data Working Group under the Code & Data Sharing Committee of the MRS Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM), this review encompasses the existing literature, supplemented by the collective experience and in‐house methodologies of its contributors, providing a community perspective that extends beyond the published record.
- Open Access
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 657 (8132) , 703-712
FNIP1 variants are associated with favourable metabolism in 1 million humans
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 657 (8132) , 703-712
Open AccessFNIP1 variants are associated with favourable metabolism in 1 million humans
- Open Access
- 10 April 2026
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 96 (2) , 516-529
The Impact and Reliability of Tissue Segmentation on In Vivo Magnetic Resonance Spectroscopy Metabolite Quantification
Purpose: Quantification of metabolite concentrations using MRS requires tissue‐dependent signal corrections. Accurate estimation of voxel tissue composition is therefore essential. Commonly used brain tissue segmentation tools differ in their algorithms and implementation, potentially introducing variability in MRS‐derived concentration estimates. This study investigates the impact and reliability of tissue segmentation on metabolite quantification. Methods: Three segmentation tools (ANTs, FSL, SPM) were evaluated using an in vivo test–retest MRI/MRS dataset. Voxelwise GM/WM/CSF fractions were applied to compute tissue‐corrected total creatine (tCr) concentrations. Linear mixed‐effects modeling, variance‐component partitioning, and intraclass correlation coefficients (ICCs) quantified tool‐, session‐, and participant‐related variance under permutation scenarios that isolated segmentation‐ and MRS‐related effects. As a benchmark for segmentation performance, comparisons with manually segmented data were conducted across three brain regions. Results: Segmentation tools produced systematically different tissue fractions that propagated into differences in tCr concentration estimates. Variance partitioning attributed 56.8%, 50.0%, and 51.3% of total tCr concentration variability to segmentation tool across the three permutations, with participant‐specific factors accounting for 34.7%, 36.2%, and 28.5%, respectively. When segmentation variability was held constant, test–retest reliability was high (ICC > 0.8) but dropped to ∼0.5 when both segmentation and MRS variability varied. Agreement with manual segmentation was region‐ and tool‐dependent, with the lowest agreement in the thalamus. Conclusion: Tissue segmentation contributes substantially to the variability in MRS‐derived metabolite concentration estimates. These results underscore the need for transparent segmentation reporting and data sharing to ensure reproducibility and cross‐study comparability in MRS research.
- 10 April 2026
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 96 (2) , 516-529
Open AccessThe Impact and Reliability of Tissue Segmentation on In Vivo Magnetic Resonance Spectroscopy Metabolite Quantification
Purpose: Quantification of metabolite concentrations using MRS requires tissue‐dependent signal corrections. Accurate estimation of voxel tissue composition is therefore essential. Commonly used brain tissue segmentation tools differ in their algorithms and implementation, potentially introducing variability in MRS‐derived concentration estimates. This study investigates the impact and reliability of tissue segmentation on metabolite quantification. Methods: Three segmentation tools (ANTs, FSL, SPM) were evaluated using an in vivo test–retest MRI/MRS dataset. Voxelwise GM/WM/CSF fractions were applied to compute tissue‐corrected total creatine (tCr) concentrations. Linear mixed‐effects modeling, variance‐component partitioning, and intraclass correlation coefficients (ICCs) quantified tool‐, session‐, and participant‐related variance under permutation scenarios that isolated segmentation‐ and MRS‐related effects. As a benchmark for segmentation performance, comparisons with manually segmented data were conducted across three brain regions. Results: Segmentation tools produced systematically different tissue fractions that propagated into differences in tCr concentration estimates. Variance partitioning attributed 56.8%, 50.0%, and 51.3% of total tCr concentration variability to segmentation tool across the three permutations, with participant‐specific factors accounting for 34.7%, 36.2%, and 28.5%, respectively. When segmentation variability was held constant, test–retest reliability was high (ICC > 0.8) but dropped to ∼0.5 when both segmentation and MRS variability varied. Agreement with manual segmentation was region‐ and tool‐dependent, with the lowest agreement in the thalamus. Conclusion: Tissue segmentation contributes substantially to the variability in MRS‐derived metabolite concentration estimates. These results underscore the need for transparent segmentation reporting and data sharing to ensure reproducibility and cross‐study comparability in MRS research.
- Open Access
- 8 April 2026
- Published by Springer Nature in Nature
- Vol. 653 (8115) , 796-808
Population-scale repeat expansions elucidate disease risk and brain atrophy
Pathogenic expansions of short tandem repeats (STRs) cause over 70 neurological diseases1,2,3. Here we performed a population-scale survey of pathogenic repeat expansions by analysing repeat length in 37 disease-associated STR loci in a diverse set of 1,020,833 samples using short-read sequencing whole-exome and whole-genome data. Consistent with previous findings, we found that the frequency of pathogenic repeats is higher than the prevalence of corresponding diseases for most loci4,5. Associations of repeat length with 7,671 binary traits captured known locus–trait associations, including HTT and Huntington’s disease, DMPK and myotonic disorders and C9orf72 and motor neuron disease, among others. Finally, we found that, even before disease diagnosis, repeat expansions in several loci strongly associate with increased levels of neurofilament light chain (NfL) and a loss of brain volume in specific disease-associated regions. For example, carriers of HTT expansions exhibited a 22.1% loss of putamen volume, and carriers of CACNA1A expansions showed a 24.6% loss of cerebellar volume. These observations suggest that both decreased brain volumes and increased NfL levels occur earlier than disease diagnosis. This study demonstrates the use of characterizing repeat expansions from short-read sequencing data in diverse population-scale cohorts and its application to epidemiology and clinical biomarker development.
- 8 April 2026
- Published by Springer Nature in Nature
- Vol. 653 (8115) , 796-808
Open AccessPopulation-scale repeat expansions elucidate disease risk and brain atrophy
Pathogenic expansions of short tandem repeats (STRs) cause over 70 neurological diseases1,2,3. Here we performed a population-scale survey of pathogenic repeat expansions by analysing repeat length in 37 disease-associated STR loci in a diverse set of 1,020,833 samples using short-read sequencing whole-exome and whole-genome data. Consistent with previous findings, we found that the frequency of pathogenic repeats is higher than the prevalence of corresponding diseases for most loci4,5. Associations of repeat length with 7,671 binary traits captured known locus–trait associations, including HTT and Huntington’s disease, DMPK and myotonic disorders and C9orf72 and motor neuron disease, among others. Finally, we found that, even before disease diagnosis, repeat expansions in several loci strongly associate with increased levels of neurofilament light chain (NfL) and a loss of brain volume in specific disease-associated regions. For example, carriers of HTT expansions exhibited a 22.1% loss of putamen volume, and carriers of CACNA1A expansions showed a 24.6% loss of cerebellar volume. These observations suggest that both decreased brain volumes and increased NfL levels occur earlier than disease diagnosis. This study demonstrates the use of characterizing repeat expansions from short-read sequencing data in diverse population-scale cohorts and its application to epidemiology and clinical biomarker development.
- Top Cited PapersOpen Access
- 13 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity
Myostatin negatively regulates skeletal muscle size in multiple species, and therefore, myostatin blockade has been therapeutically explored to promote muscle growth in humans, including to counter the muscle loss seen in obese humans using GLP1R agonists. In this study, we present results from a large multi-cohort genetic association analysis, using data from 1.1 million individuals to examine the effects of function-disrupting mutations in the myostatin gene (MSTN) on traits relevant to body composition and cardiometabolic health. Carriers of function-disrupting variants display decreased adiposity, an increase in lean mass, and increased grip strength and creatinine levels. We further characterize the effects of these variants on body composition using whole-body MRI data from UK Biobank, leveraging deep learning models to perform automated image segmentation for 77,572 individuals. Among mutation carriers increased muscle mass is observed across multiple muscle groups, with heterozygote carriers of loss-of-function-like mutations exhibiting increases in excess of 10%. Our findings demonstrate that lifelong reduction in myostatin function enhances muscle size and strength in humans while decreasing body adiposity, providing insights into the potential benefits and safety of long-term therapeutic blockade of myostatin signaling.
- 13 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Top Cited PapersOpen AccessHumans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity
Myostatin negatively regulates skeletal muscle size in multiple species, and therefore, myostatin blockade has been therapeutically explored to promote muscle growth in humans, including to counter the muscle loss seen in obese humans using GLP1R agonists. In this study, we present results from a large multi-cohort genetic association analysis, using data from 1.1 million individuals to examine the effects of function-disrupting mutations in the myostatin gene (MSTN) on traits relevant to body composition and cardiometabolic health. Carriers of function-disrupting variants display decreased adiposity, an increase in lean mass, and increased grip strength and creatinine levels. We further characterize the effects of these variants on body composition using whole-body MRI data from UK Biobank, leveraging deep learning models to perform automated image segmentation for 77,572 individuals. Among mutation carriers increased muscle mass is observed across multiple muscle groups, with heterozygote carriers of loss-of-function-like mutations exhibiting increases in excess of 10%. Our findings demonstrate that lifelong reduction in myostatin function enhances muscle size and strength in humans while decreasing body adiposity, providing insights into the potential benefits and safety of long-term therapeutic blockade of myostatin signaling.
- Open Access
Resolving Cellular Morphology in the Human Brain with Multiparametric Diffusion MR Spectroscopy
Diffusion-weighted magnetic resonance spectroscopy (dMRS) noninvasively probes the diffusion of mostly intracellular metabolites and can therefore report on brain microstructure with a cell-type specificity that water-based diffusion MRI cannot achieve. However, the morphological information accessible to conventional dMRS is limited: estimating both cell-body (soma) and neurite dimensions from a single diffusion-encoding scheme is an ill-posed problem, and neither ultra-high b-value nor diffusion-time-dependent measurements alone distinguish soma size from neurite radius. Here we introduce multiparametric dMRS in the human brain, combining diffusion-time-dependent encoding (apparent diffusion coefficient, ADC, and diffusion kurtosis, K, sampled over diffusion times of 6ms to 250ms and b-values up to 8ms/μm2) with double-diffusion-encoded spectroscopy (DDES). Using Monte-Carlo analysis, we show that fitting a two-compartment (soma+neurite) tissue model to diffusion-time data alone is degenerate, admitting two near-indistinguishable solutions. Adding the orthogonal angular information from DDES breaks this degeneracy: jointly fitting both experiments converges to a single, biophysically plausible solution irrespective of initialization, yielding cell-type-specific estimates of intrinsic diffusivity, soma radius, neurite radius, and neurite signal fraction for neuronal (NAA, glutamate) and glial (choline, myo-inositol) metabolites. Metabolite microscopic anisotropy approaches unity, consistent with predominantly intra-neurite diffusion, while simultaneously acquired water data reveal short-range structural disorder and intercompartmental exchange (15ms). Multiparametric dMRS thus extends the standard model of metabolite diffusion by a soma compartment and offers a route toward in vivo, cell-type-specific morphometry of neurons and glia in humans -a foundation for biomarkers in conditions where soma and neurite morphology are altered.
Open AccessResolving Cellular Morphology in the Human Brain with Multiparametric Diffusion MR Spectroscopy
Diffusion-weighted magnetic resonance spectroscopy (dMRS) noninvasively probes the diffusion of mostly intracellular metabolites and can therefore report on brain microstructure with a cell-type specificity that water-based diffusion MRI cannot achieve. However, the morphological information accessible to conventional dMRS is limited: estimating both cell-body (soma) and neurite dimensions from a single diffusion-encoding scheme is an ill-posed problem, and neither ultra-high b-value nor diffusion-time-dependent measurements alone distinguish soma size from neurite radius. Here we introduce multiparametric dMRS in the human brain, combining diffusion-time-dependent encoding (apparent diffusion coefficient, ADC, and diffusion kurtosis, K, sampled over diffusion times of 6ms to 250ms and b-values up to 8ms/μm2) with double-diffusion-encoded spectroscopy (DDES). Using Monte-Carlo analysis, we show that fitting a two-compartment (soma+neurite) tissue model to diffusion-time data alone is degenerate, admitting two near-indistinguishable solutions. Adding the orthogonal angular information from DDES breaks this degeneracy: jointly fitting both experiments converges to a single, biophysically plausible solution irrespective of initialization, yielding cell-type-specific estimates of intrinsic diffusivity, soma radius, neurite radius, and neurite signal fraction for neuronal (NAA, glutamate) and glial (choline, myo-inositol) metabolites. Metabolite microscopic anisotropy approaches unity, consistent with predominantly intra-neurite diffusion, while simultaneously acquired water data reveal short-range structural disorder and intercompartmental exchange (15ms). Multiparametric dMRS thus extends the standard model of metabolite diffusion by a soma compartment and offers a route toward in vivo, cell-type-specific morphometry of neurons and glia in humans -a foundation for biomarkers in conditions where soma and neurite morphology are altered.
- Open Access
The Consequences of Statistical Tests on Using Proxy Measurements in Place of Gold Standard Measurements: An Application to Magnetic Resonance Spectroscopy
The use of proxy measurements in biomedical science is ubiquitous, due to the infeasibility or unavailability of gold-standard (i.e., most precise, accurate, and/or validated) measurements. For example, in magnetic resonance spectroscopy (MRS), short-echo time (TE) sequences are frequently employed to estimate difficult-to-measure metabolites such as GABA, despite J-difference editing being the recommended gold-standard for improved metabolic specificity. This work investigates the critical relationship between the correlation of proxy and gold-standard measurements and the associated false positive (FPR) and false negative (FNR) rates of statistical tests performed on proxy measurements. Through statistical simulations, we demonstrate that even moderately high correlations (0.6-0.7), reported in the literature for short-TE vs. J-edited estimated GABA, can lead to drastically inflated FPRs and FNRs. We show that these rates are highly sensitive to the magnitude of any introduced bias in the proxy measurement (δ) and the underlying true effect size (Δ). For instance, a small, unmeasured bias in short-TE estimated GABA, potentially arising from macromolecule contamination, can substantially inflate FPRs. Conversely, imperfect correlation can significantly reduce statistical power, leading to high FNRs, which may explain some discrepancies within the literature. Although this work focuses specifically on the relationship between short-TE and MEGA-edited GABA, the arguments presented here apply more broadly to other difficult-to-measure metabolites in MRS (e.g., glutathione, 2-hydroxyglutarate), or generally to any circumstance where statistical tests are performed on the readily available proxy measurements in place of gold-standard measurements.
Open AccessThe Consequences of Statistical Tests on Using Proxy Measurements in Place of Gold Standard Measurements: An Application to Magnetic Resonance Spectroscopy
The use of proxy measurements in biomedical science is ubiquitous, due to the infeasibility or unavailability of gold-standard (i.e., most precise, accurate, and/or validated) measurements. For example, in magnetic resonance spectroscopy (MRS), short-echo time (TE) sequences are frequently employed to estimate difficult-to-measure metabolites such as GABA, despite J-difference editing being the recommended gold-standard for improved metabolic specificity. This work investigates the critical relationship between the correlation of proxy and gold-standard measurements and the associated false positive (FPR) and false negative (FNR) rates of statistical tests performed on proxy measurements. Through statistical simulations, we demonstrate that even moderately high correlations (0.6-0.7), reported in the literature for short-TE vs. J-edited estimated GABA, can lead to drastically inflated FPRs and FNRs. We show that these rates are highly sensitive to the magnitude of any introduced bias in the proxy measurement (δ) and the underlying true effect size (Δ). For instance, a small, unmeasured bias in short-TE estimated GABA, potentially arising from macromolecule contamination, can substantially inflate FPRs. Conversely, imperfect correlation can significantly reduce statistical power, leading to high FNRs, which may explain some discrepancies within the literature. Although this work focuses specifically on the relationship between short-TE and MEGA-edited GABA, the arguments presented here apply more broadly to other difficult-to-measure metabolites in MRS (e.g., glutathione, 2-hydroxyglutarate), or generally to any circumstance where statistical tests are performed on the readily available proxy measurements in place of gold-standard measurements.
- Open Access
Metabolomics Ex/GWAS in the Amish reveals novel insights into cardiometabolic disease pathways
We conducted an exome and genome-wide association study (Ex/GWAS) of 1,015 metabolites in serum samples from 5,981 Amish adults. We identified 149 functional or likely functional genetic variants, based on CADD scores significantly associated ( P < 5.8 x 10 -8 ) with 519 metabolite levels, 69 of which were >10-fold enriched in the Amish versus Europeans in gnomAD. We discovered novel associations involving a PCK2 splice-donor variant (rs138881435) and metabolites important for energy metabolism and mitochondrial function. In UK Biobank participants, this variant was associated with increased longitudinal relaxation time (T1) values on liver MRI suggesting increased inflammation and fibrosis. Furthermore, we found novel associations involving ENPEP stop-gain variant (rs33966350) and peptide and amino acid metabolite levels, implicating ENPEP’s roles in blood pressure regulation. Additional known and novel genetic variant-metabolite associations were identified including genes involved in Amish-enriched Mendelian diseases and cardiometabolic traits, providing insights into underlying mechanisms of these disorders.
Open AccessMetabolomics Ex/GWAS in the Amish reveals novel insights into cardiometabolic disease pathways
We conducted an exome and genome-wide association study (Ex/GWAS) of 1,015 metabolites in serum samples from 5,981 Amish adults. We identified 149 functional or likely functional genetic variants, based on CADD scores significantly associated ( P < 5.8 x 10 -8 ) with 519 metabolite levels, 69 of which were >10-fold enriched in the Amish versus Europeans in gnomAD. We discovered novel associations involving a PCK2 splice-donor variant (rs138881435) and metabolites important for energy metabolism and mitochondrial function. In UK Biobank participants, this variant was associated with increased longitudinal relaxation time (T1) values on liver MRI suggesting increased inflammation and fibrosis. Furthermore, we found novel associations involving ENPEP stop-gain variant (rs33966350) and peptide and amino acid metabolite levels, implicating ENPEP’s roles in blood pressure regulation. Additional known and novel genetic variant-metabolite associations were identified including genes involved in Amish-enriched Mendelian diseases and cardiometabolic traits, providing insights into underlying mechanisms of these disorders.
- Open Access
Benchmarking the Impact of Anatomical Segmentation on In Vivo Magnetic Resonance Spectroscopy
Purpose: Estimation of metabolite concentrations in brain magnetic resonance spectroscopy (MRS) requires correction for differences in tissue water content, relaxation properties, and the proportions of gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). Accurate knowledge of the relative proportions of these tissue classes within the volume of interest is therefore essential for reliable quantification. Commonly used brain segmentation tools differ in their algorithms, priors, and implementation, potentially introducing variability in MRS-derived concentration estimates. This study investigates the impact of segmentation software on estimated absolute concentrations. Methods: Three segmentation software tools, ANTs, FSL, and SPM, were evaluated. Segmentations were applied to an in vivo test-retest MR dataset to assess (1) differences in estimated tissue fractions, and (2) how these differences propagate into tissue-corrected metabolite concentrations. As an additional validity check and biological benchmark of segmentation performance, age-related associations with GM and total creatine (tCr) were examined. Results: Significant differences ( p < 0.0001) were observed in tissue fraction estimates between segmentation tools, leading to differences in metabolite concentration estimates of up to 9% under identical acquisition and modeling conditions. Although the strength of the correlation varied between segmentation methods, no statistically significant differences were found. Conclusion: The choice of segmentation methodology contributed substantially to variability in MRS “absolute” metabolite concentration estimates. These results underscore the need for transparent segmentation reporting to ensure reproducibility and cross-study comparability in MRS research. Quantifying the segmentation-driven variability allows researchers to contextualize cross-study differences, helping determine whether observed effects are methodological or biologically meaningful.
Open AccessBenchmarking the Impact of Anatomical Segmentation on In Vivo Magnetic Resonance Spectroscopy
Purpose: Estimation of metabolite concentrations in brain magnetic resonance spectroscopy (MRS) requires correction for differences in tissue water content, relaxation properties, and the proportions of gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). Accurate knowledge of the relative proportions of these tissue classes within the volume of interest is therefore essential for reliable quantification. Commonly used brain segmentation tools differ in their algorithms, priors, and implementation, potentially introducing variability in MRS-derived concentration estimates. This study investigates the impact of segmentation software on estimated absolute concentrations. Methods: Three segmentation software tools, ANTs, FSL, and SPM, were evaluated. Segmentations were applied to an in vivo test-retest MR dataset to assess (1) differences in estimated tissue fractions, and (2) how these differences propagate into tissue-corrected metabolite concentrations. As an additional validity check and biological benchmark of segmentation performance, age-related associations with GM and total creatine (tCr) were examined. Results: Significant differences ( p < 0.0001) were observed in tissue fraction estimates between segmentation tools, leading to differences in metabolite concentration estimates of up to 9% under identical acquisition and modeling conditions. Although the strength of the correlation varied between segmentation methods, no statistically significant differences were found. Conclusion: The choice of segmentation methodology contributed substantially to variability in MRS “absolute” metabolite concentration estimates. These results underscore the need for transparent segmentation reporting to ensure reproducibility and cross-study comparability in MRS research. Quantifying the segmentation-driven variability allows researchers to contextualize cross-study differences, helping determine whether observed effects are methodological or biologically meaningful.
- 4 June 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 94 (3) , 895-904
Constrained optimized water suppression for 1H MR spectroscopy
Purpose: Water suppression is a necessary component to standard MR spectroscopy experiments due to the approximately 5000–10 000‐fold higher water concentration and signal intensity compared with that of the metabolites and macromolecules of interest. Here, a novel algorithm referred to as constrained optimized water suppression (COWS) was developed, which enables generation of effective water suppression modules with an arbitrary number of radiofrequency (RF) pulses, and flexibly accommodates minimum durations between pulses, minimum total module duration, and maximum flip angles.Methods: We use the COWS algorithm to create a water‐suppression module with seven pulses, the same number of RF pulses as typical VAPOR7, at a reduced module duration of 236 ms, referred to as COWS(7;236), as well as one at the typical VAPOR duration but with an increased number of RF pulses, referred to as COWS(12;626). Experimentally, both COWS schemes were compared with variable power radio frequency pulses with optimized relaxation delays (VAPOR) using single‐voxel spectroscopy in the prefrontal cortex, the posterior frontal lobe, and the occipital lobe from data collected from 10 participants on a 3T Siemens MRI scanner.Results: We found that both COWS(7;236) and COWS(12;626) perform similar to VAPOR7 for metabolites, whereas COWS(7;236) had improved performance than VAPOR for macromolecules at a reduced 236‐ms duration.Conclusion: COWS can be used to develop flexible study‐specific water suppression that can perform similarly for metabolite spectra or with improved performance for macromolecule spectra compared with VAPOR7, at a lower module duration.
- 4 June 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 94 (3) , 895-904
Constrained optimized water suppression for 1H MR spectroscopy
Purpose: Water suppression is a necessary component to standard MR spectroscopy experiments due to the approximately 5000–10 000‐fold higher water concentration and signal intensity compared with that of the metabolites and macromolecules of interest. Here, a novel algorithm referred to as constrained optimized water suppression (COWS) was developed, which enables generation of effective water suppression modules with an arbitrary number of radiofrequency (RF) pulses, and flexibly accommodates minimum durations between pulses, minimum total module duration, and maximum flip angles.Methods: We use the COWS algorithm to create a water‐suppression module with seven pulses, the same number of RF pulses as typical VAPOR7, at a reduced module duration of 236 ms, referred to as COWS(7;236), as well as one at the typical VAPOR duration but with an increased number of RF pulses, referred to as COWS(12;626). Experimentally, both COWS schemes were compared with variable power radio frequency pulses with optimized relaxation delays (VAPOR) using single‐voxel spectroscopy in the prefrontal cortex, the posterior frontal lobe, and the occipital lobe from data collected from 10 participants on a 3T Siemens MRI scanner.Results: We found that both COWS(7;236) and COWS(12;626) perform similar to VAPOR7 for metabolites, whereas COWS(7;236) had improved performance than VAPOR for macromolecules at a reduced 236‐ms duration.Conclusion: COWS can be used to develop flexible study‐specific water suppression that can perform similarly for metabolite spectra or with improved performance for macromolecule spectra compared with VAPOR7, at a lower module duration.